CLAI Stock Overview
Engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Cel AI PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.00085 |
| 52 Week High | UK£0.008 |
| 52 Week Low | UK£0.0003 |
| Beta | -1.5 |
| 1 Month Change | 61.90% |
| 3 Month Change | 34.92% |
| 1 Year Change | -69.09% |
| 3 Year Change | -98.83% |
| 5 Year Change | n/a |
| Change since IPO | -99.55% |
Recent News & Updates
Shareholder Returns
| CLAI | GB Personal Products | GB Market | |
|---|---|---|---|
| 7D | 41.7% | -0.7% | 0.2% |
| 1Y | -69.1% | 18.4% | 2.3% |
Return vs Industry: CLAI underperformed the UK Personal Products industry which returned 19.5% over the past year.
Return vs Market: CLAI underperformed the UK Market which returned 2.7% over the past year.
Price Volatility
| CLAI volatility | |
|---|---|
| CLAI Average Weekly Movement | 28.5% |
| Personal Products Industry Average Movement | 3.7% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.4% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: CLAI's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: CLAI's weekly volatility has increased from 19% to 28% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 5 | Mike Edwards | www.getcel.ai |
Cel AI PLC, together with its subsidiaries, engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare and ingestible products. It offers its products through retailers; direct to consumers through its website; and online.
Cel AI PLC Fundamentals Summary
| CLAI fundamental statistics | |
|---|---|
| Market cap | UK£511.91k |
| Earnings (TTM) | -UK£2.11m |
| Revenue (TTM) | UK£54.16k |
9.5x
P/S Ratio-0.2x
P/E RatioIs CLAI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLAI income statement (TTM) | |
|---|---|
| Revenue | UK£54.16k |
| Cost of Revenue | UK£20.15k |
| Gross Profit | UK£34.01k |
| Other Expenses | UK£2.14m |
| Earnings | -UK£2.11m |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0035 |
| Gross Margin | 62.80% |
| Net Profit Margin | -3,892.32% |
| Debt/Equity Ratio | 0% |
How did CLAI perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 06:31 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/02/29 |
| Annual Earnings | 2023/08/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cel AI PLC is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|